Cargando…

Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose‐Escalation Multicenter Study

BACKGROUND: Injectable daxibotulinumtoxinA (an investigational botulinum toxin, RT002) may offer a more prolonged duration of response—and therefore less frequent dosing—than onabotulinumtoxinA. OBJECTIVES: To perform a phase 2, open‐label, dose‐escalation study to assess the efficacy and safety of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jankovic, Joseph, Truong, Daniel, Patel, Atul T., Brashear, Allison, Evatt, Marian, Rubio, Roman G., Oh, Chad K., Snyder, Daniel, Shears, Gill, Comella, Cynthia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032882/ https://www.ncbi.nlm.nih.gov/pubmed/30009213 http://dx.doi.org/10.1002/mdc3.12613

Ejemplares similares

Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines
por: Humphrey, Shannon, et al.
Publicado: (2023)

DAXI (DaxibotulinumtoxinA) – An Innovative Approach for Frown Lines
por: Mussarat, Abdullah, et al.
Publicado: (2023)

Impact of Glabellar Injection Technique With DaxibotulinumtoxinA for Injection on Brow Position
por: Bertucci, Vince, et al.
Publicado: (2022)

Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A
por: Solish, Nowell, et al.
Publicado: (2021)

Progressive Improvement in Static Glabellar Lines After Repeated Treatment With DaxibotulinumtoxinA for Injection
por: Glogau, Richard, et al.
Publicado: (2021)

Treatment of Upper Facial Lines With DaxibotulinumtoxinA for Injection: Results From an Open-Label Phase 2 Study
por: Dover, Jeffrey S., et al.
Publicado: (2023)

Efficacy and Safety of DaxibotulinumtoxinA for Injection in the Treatment of Glabellar Lines by Age and Race: Subgroup Analysis of the SAKURA Clinical Trials
por: Solish, Nowell, et al.
Publicado: (2022)

Bridging the Gap: Sustained Treatment Effect of Glabellar Lines With Twice-A-Year Treatment With DaxibotulinumtoxinA
por: Dover, Jeffrey S., et al.
Publicado: (2023)

Impact of DaxibotulinumtoxinA for Injection on Brow Position and Frontalis Muscle Activity Following Treatment of Glabellar Lines
por: Solish, Nowell, et al.
Publicado: (2022)

Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 Trials
por: Gallagher, Conor J., et al.
Publicado: (2023)

Prior Botulinum Toxin Treatment Does Not Impact Efficacy or Safety in Clinical Trials: Analysis of DaxibotulinumtoxinA for Injection in the SAKURA Program
por: Cohen, Joel L., et al.
Publicado: (2021)

DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Results from Each of Two Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Studies (SAKURA 1 and SAKURA 2)
por: Carruthers, Jean D., et al.
Publicado: (2020)

DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Efficacy Results From SAKURA 3, a Large, Open-Label, Phase 3 Safety Study
por: Fabi, Sabrina G., et al.
Publicado: (2021)

A Large, Open-Label, Phase 3 Safety Study of DaxibotulinumtoxinA for Injection in Glabellar Lines: A Focus on Safety From the SAKURA 3 Study
por: Green, Jeremy B., et al.
Publicado: (2021)

A randomized, double-blind study of repeated incobotulinumtoxinA (Xeomin(®)) in cervical dystonia
por: Evidente, Virgilio Gerald H., et al.
Publicado: (2013)

Efficacy and Safety of IncobotulinumtoxinA in Subjects Previously Treated with Botulinum Toxin Versus Toxin-Naïve Subjects with Cervical Dystonia
por: Fernandez, Hubert H., et al.
Publicado: (2013)

Botulinum toxin type A in the treatment of patients with cervical dystonia
por: Brashear, Allison
Publicado: (2009)

An international survey of patients with cervical dystonia
por: Comella, Cynthia, et al.
Publicado: (2015)

Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy)
por: Charles, P. David, et al.
Publicado: (2014)

The Dystonia Coalition: A Multicenter Network for Clinical and Translational Studies
por: Kilic-Berkmen, Gamze, et al.
Publicado: (2021)

Clinical and genetic features of cervical dystonia in a large multicenter cohort
por: LeDoux, Mark S., et al.
Publicado: (2016)

AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions
por: Lew, Mark F., et al.
Publicado: (2021)

The vital role of natural history studies in rare disease: insights from X-linked dystonia parkinsonism
por: Haq, Ihtsham, et al.
Publicado: (2023)

Postural Directionality and Head Tremor in Cervical Dystonia
por: Chen, Qiyu, et al.
Publicado: (2020)

Sports-Related Dystonia
por: Lenka, Abhishek, et al.
Publicado: (2021)

Treatment of dystonia and tics
por: Bellows, Steven, et al.
Publicado: (2019)

Bupropion-Induced Acute Dystonia with Dose Escalation and Use of Naranjo Nomogram
por: Wasif, Nawal, et al.
Publicado: (2017)

Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia
por: Comella, Cynthia, et al.
Publicado: (2020)

Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE)
por: Jankovic, Joseph, et al.
Publicado: (2011)

Correction to: Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia
por: Comella, Cynthia, et al.
Publicado: (2020)

Sensory Tricks Are Associated with Higher Sleep-Related Quality of Life in Cervical Dystonia
por: Benadof, Casey N., et al.
Publicado: (2019)

A Functional Magnetic Resonance Imaging Study of Head Movements in Cervical Dystonia
por: Prudente, Cecília N., et al.
Publicado: (2016)

Descriptive Epidemiology of Cervical Dystonia
por: Defazio, Giovanni, et al.
Publicado: (2013)

Does Raising the Arms Modify Head Tremor Severity in Cervical Dystonia?
por: Cisneros, Elizabeth, et al.
Publicado: (2021)

Validation of a guideline to reduce variability in diagnosing cervical dystonia
por: Defazio, Giovanni, et al.
Publicado: (2023)

Real de-escalation or escalation in disguise?
por: Banys-Paluchowski, Maggie, et al.
Publicado: (2023)

Long-Term Efficacy and Safety of Botulinum Toxin Injections in Dystonia
por: Ramirez-Castaneda, Juan, et al.
Publicado: (2013)

Patient selection and injection techniques for botulinum neurotoxin in oromandibular dystonia
por: Bhidayasiri, Roongroj, et al.
Publicado: (2022)

Efficacy and safety of two incobotulinumtoxinA injection intervals in cervical dystonia patients with inadequate benefit from standard injection intervals of botulinum toxin: Phase 4, open-label, randomized, noninferiority study
por: Comella, Cynthia, et al.
Publicado: (2022)

Hold that pose: capturing cervical dystonia's head deviation severity from video
por: Zhang, Zheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_71uj6plkgt7lrkm1ugoerpj7u6